abiraterone

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), low-volume castration-resistant after inadequate therapy, as well as progressing castration-resistant prostate cancer during or after docetaxel chemotherapy.

Form: tablets

ATC: L02BX03

Manufacturer: Amneal Pharmaceuticals Private Limited

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), low-volume castration-resistant after inadequate androgen deprivation therapy, as well as progressive castration-resistant during or after docetaxel chemotherapy.

Form: tablets

ATC: L02BX03

Manufacturer: MSN Laboratories Private Limited

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: castration-resistant prostate cancer (with a mild course after androgen therapy or upon progression after docetaxel chemotherapy), as well as newly diagnosed high-risk hormone-sensitive prostate cancer in combination with androgen deprivation therapy.

Form: tablets, film-coated

ATC: L02BX03

Manufacturer: Teva Pharmaceutical Industries Ltd.

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed high-risk hormone-sensitive, as well as castration-resistant (mild course after androgen blockade or progressing after docetaxel chemotherapy).

Form: tablets

ATC: L02BX03

Manufacturer: Synthon Hispania, S.L. (manufacturing, primary and secondary packaging, quality control, batch release)

The drug is prescribed to adult men for the treatment of metastatic prostate cancer at various stages (both hormone-sensitive and castration-resistant), particularly after unsuccessful chemotherapy.

Form: tablets, film-coated

ATC: L02BX03

Manufacturer: Remedica Limited

The drug is used in combination with prednisone or prednisolone for the treatment of adult men with metastatic prostate cancer: newly diagnosed hormone-sensitive (high risk), castration-resistant with mild course, or those progressing after docetaxel chemotherapy.

Form: tablets

ATC: L02BX03

Manufacturer: Hetero Labs Limited

The drug is intended for the treatment of adult men with metastatic castration-resistant prostate cancer. It is used in cases where the disease has an asymptomatic or mild course and chemotherapy is not indicated, as well as in cases of disease progression following previous docetaxel chemotherapy. Teronred is taken in combination with prednisone or prednisolone.

Form: tablets, film-coated

ATC: L02BX03

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7